- Home
- TARA vs AMPY Comparison
TARA vs AMPY Comparison
Compare TARA & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- AMPY
- Stock Information
- Founded
- TARA N/A
- AMPY 2011
- Country
- TARA United States
- AMPY United States
- Employees
- TARA N/A
- AMPY N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- AMPY Oil & Gas Production
- Sector
- TARA Health Care
- AMPY Energy
- Exchange
- TARA Nasdaq
- AMPY Nasdaq
- Market Cap
- TARA 136.3M
- AMPY 157.7M
- IPO Year
- TARA N/A
- AMPY 2011
- Fundamental
- Price
- TARA $4.26
- AMPY $3.79
- Analyst Decision
- TARA Strong Buy
- AMPY Strong Buy
- Analyst Count
- TARA 4
- AMPY 3
- Target Price
- TARA $22.67
- AMPY $10.00
- AVG Volume (30 Days)
- TARA 225.7K
- AMPY 580.6K
- Earning Date
- TARA 03-05-2025
- AMPY 03-05-2025
- Dividend Yield
- TARA N/A
- AMPY N/A
- EPS Growth
- TARA N/A
- AMPY N/A
- EPS
- TARA N/A
- AMPY 0.31
- Revenue
- TARA N/A
- AMPY $294,680,100.00
- Revenue This Year
- TARA N/A
- AMPY $26.99
- Revenue Next Year
- TARA N/A
- AMPY $21.93
- P/E Ratio
- TARA N/A
- AMPY $12.21
- Revenue Growth
- TARA N/A
- AMPY 1.72
- 52 Week Low
- TARA $1.60
- AMPY $3.54
- 52 Week High
- TARA $10.48
- AMPY $8.15
- Technical
- Relative Strength Index (RSI)
- TARA 48.51
- AMPY 35.80
- Support Level
- TARA $4.41
- AMPY $3.72
- Resistance Level
- TARA $4.63
- AMPY $4.06
- Average True Range (ATR)
- TARA 0.27
- AMPY 0.18
- MACD
- TARA 0.02
- AMPY 0.05
- Stochastic Oscillator
- TARA 34.75
- AMPY 18.75
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.